L794-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3-oxo-3,4-dihydro-2H-1,4-benzothiazine-2-carbonyl)piperidine-4-carboxamide

L794-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3-oxo-3,4-dihydro-2H-1,4-benzothiazine-2-carbonyl)piperidine-4-carboxamide
L794-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3-oxo-3,4-dihydro-2H-1,4-benzothiazine-2-carbonyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L794-0151
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3-oxo-3,4-dihydro-2H-1,4-benzothiazine-2-carbonyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L794-0151

Molecular Formula

C23H23N3O5S (C23 H23 N3 O5 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(3-oxo-3,4-dihydro-2H-1,4-benzothiazine-2-carbonyl)piperidine-4-carboxamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-1-(3-oxo-34-dihydro-2H-14-benzothiazine-2-carbonyl)piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1C(C1Sc(cccc2)c2NC1=O)=O)Nc(cc1)cc2c1OCCO2

InChI

InChI=1S/C23H23N3O5S/c27-21(24-15-5-6-17-18(13-15)31-12-11-30-17)14-7-9-26(10-8-14)23(29)20-22(28)25-16-3-1-2-4-19(16)32-20/h1-6,13-14,20H,7-12H2,(H,24,27)(H,25,28)/t20-/m1/s1

InChI Key

NOKWTYSDWIPTCR-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD15134962

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.129

Distribution Coefficient, logD

1.129

Water Solubility, LogSw

-2.37

Polar Surface Area

80.679

Acid Dissociation Constant (pKa)

10.77

Base Dissociation Constant (pKb)

1.67

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.80

L794-0151 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L794-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L794-0151?
Check Price and Availability of L794-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L794-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L794-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L794-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L794-0151 available by request